Back to companies

Shin Poong Pharm Co Ltd: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Shin Poong Pharm Co Ltd (Shin Poong) is a pharmaceutical company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company's pipeline products include SP-8257, SP-8356, CandeAmlo plus, SP-8203, CandeAmlo, EzeRosu, SP-LI-N1, Hyaltop, Hyalflex, Medicurtain Plus, Medicurtain, Pyramax tablets, Pyramax granules for the indication of cardiovascular disease, bone related disease, inflammatory disease, and infectious disease. Its technology platform utilizes to Research on months-long sustained effects of siRNA and peptide, and Double layer formulation. The company brands portfolio includes CandeAmlo plus, CandeAmlo, EzeRosu, Hyaltop, Hyalflex, Medicurtain, and Pyramax. Shin Poong is headquartered in Seoul, South Korea.

Gain a 360-degree view of Shin Poong Pharm Co Ltd and make more informed decisions for your business Gain a 360-degree view of Shin Poong Pharm Co Ltd and make more informed decisions for your business Register your interest
Headquarters South Korea

Address 7, Wonsi-Ro, Danwon-Gu, Gyeonggi-do, Ansan-Si, Seoul, 15610


Telephone 82 2 21893400

No of Employees 792

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 019170 (KRX)

Revenue (2024) $165.2M 6.1% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ 157.4% (2024 vs 2023)

Market Cap* $288.1M

Net Profit Margin (2024) XYZ 154.0% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Shin Poong Pharm Co Ltd premium industry data and analytics

280+

Marketed Drugs

Understand Shin Poong Pharm Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

50+

Clinical Trials

Determine Shin Poong Pharm Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Shin Poong Pharm Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Pipeline Drugs

Identify which of Shin Poong Pharm Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Shin Poong Pharm Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Pipeline CandeAmlo plus
Stroke and Atherosclerosis: CandeAmlo
SP-8257 EzeRosu
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Shin Poong Pharm Co Ltd portfolio and identify potential areas for collaboration Understand Shin Poong Pharm Co Ltd portfolio and identify potential areas for collaboration Register your interest

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Regulatory Approval In July, the company received approval for Hyalplex Injection (sodium hyaluronate gel cross-linked with hexamethylenediamine).
2024 New Products/Services In April, Admiles unveiled Lutein Zeaxanthin in 10 mm ultra-small mini capsules.
2023 New Products/Services In September, Admiles launched two new products, Fishbone Calcium Magnesium Vitamin D and Supercritical Altige Omega 3.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Register your interest
Image for loader

Competitor Comparison

Key Parameters Shin Poong Pharm Co Ltd Boryung Co Ltd Ildong Pharmaceutical Co Ltd Kolon Life Science Inc Binex Co Ltd
Headquarters South Korea South Korea South Korea South Korea South Korea
City Ansan-Si Seoul Seoul Seoul Busan
State/Province Seoul - - - Yeongnam
No. of Employees 792 1,144 1,433 432 390
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Yoo Je Man Director Non Executive Board - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Shin Poong Pharm Co Ltd key executives to enhance your sales strategy Gain insight into Shin Poong Pharm Co Ltd key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?